Cargando…
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
This work illustrates the development of a dry inhalation powder of cyclosporine-A for the prevention of rejection after lung transplantation and for the treatment of COVID-19. The influence of excipients on the spray-dried powder’s critical quality attributes was explored. The best-performing powde...
Autores principales: | D’Angelo, Davide, Quarta, Eride, Glieca, Stefania, Varacca, Giada, Flammini, Lisa, Bertoni, Simona, Brandolini, Martina, Sambri, Vittorio, Grumiro, Laura, Gatti, Giulia, Dirani, Giorgio, Taddei, Francesca, Bianchera, Annalisa, Sonvico, Fabio, Bettini, Ruggero, Buttini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055879/ https://www.ncbi.nlm.nih.gov/pubmed/36986883 http://dx.doi.org/10.3390/pharmaceutics15031023 |
Ejemplares similares
-
RespiCell(TM): An Innovative Dissolution Apparatus for Inhaled Products
por: Sonvico, Fabio, et al.
Publicado: (2021) -
Recent Patents on Nasal Vaccines Containing Nanoadjuvants
por: Candela, Francesco, et al.
Publicado: (2022) -
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
por: Villetti, Marcos Antonio, et al.
Publicado: (2021) -
Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021) -
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens
por: Canelli, Elena, et al.
Publicado: (2023)